Detection of parvovirus B19 capsid proteins in lymphocytic cells in synovial tissue of autoimmune chronic arthritis

Modern Pathology

Volumn 16, Issue 8, 2003, Pages 811-817

  Mehraein, Yasmin ^a   Lennerz, Carsten ^a   Ehlhardt, Sandra ^a   Venzke, Thorsten ^a   Ojak, Andreas ^b   Remberger, Klaus ^a   Zang, Klaus D ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b Bundesknappsch's Hosp Puettlingen   (Germany)

Author keywords

Autoimmune arthritis; Immunohistochemistry; Lymphocytes; Parvovirus B19; Rheumatoid arthritis

Indexed keywords

CAPSID PROTEIN; CD20 ANTIGEN; CD3 ANTIGEN; PROTEIN VP1; PROTEIN VP2; UNCLASSIFIED DRUG; VIRUS DNA;

ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CHRONIC ARTHRITIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LYMPHOCYTE CULTURE; PARVOVIRUS; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PSORIATIC ARTHRITIS; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVITIS; SYNOVIUM; T LYMPHOCYTE; VIRUS DETECTION; VIRUS EXPRESSION; VIRUS INFECTION; VIRUS REPLICATION;

ARTHRITIS; AUTOIMMUNE DISEASES; CAPSID PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES; MALE; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; SYNOVIAL MEMBRANE;

EID: 0042890276     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MP.0000083145.68333.9B     Document Type: Article

References (35)

1. Phillips PE. Viral arthritis. Curr Opin Rheumatol 1997;9:337-44.
2. Krause A, Kamradt T, Burmester GR. Potential infectious agents in the induction of arthritides. Curr Opin Rheumatol 1996;8:203-9.
3. Takeda T, Mizugaki Y, Matsubara L, Imai S, Koike T, Takada K. Lytic Epstein-Barr virus infection in the synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum 2000;43: 1218-25.
4. Alspaugh MA, Tan EM. Serum antibody in rheumatoid arthritis reactive with cell associated antigen: demonstration by precipitation and immunofluorescence. Arthritis Rheum 1976;19:711-9.
5. Scully TB, Walker PJ, Moss DJ, Pope JH. Identification of multiple Epstein-Barr virus-induced nuclear antigens with sera from patients with rheumatoid arthritis. J Virol 1984;52:88-93.
6. Takahashi Y, Murai C, Shibata S, Munakata Y, Ishii T, Ishii K, et al. Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc Natl Acad Sci U S A 1998;95:8227-32.
7. Saal JG, Steidle M, Einsele H, Muller CA, Fritz P, Zacher J. Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis. Rheumatol Int 1992;12:147-51.
8. Stahl H-D, Hubner B, Seidl B, Liebert UG, van der Heijden IM, Wilbrink B, et al. Detection of multiple viral DNA species in synovial tissue and fluid of patients with early arthritis. Ann Rheum Dis 2000;59:342-6.
9. Newkirk MM, Watanabe DKN, Leclerc J, Lambert N, Shiroky JB. Detection of cytomegalovirus, Epstein-Barr virus and herpes virus-6 in patients with rheumatoid arthritis with or without Sjögren's syndrome. Br J Rheumatol 1994;33:317-22.
10. Nikkari S, Luukkainen R, Mottonen T, Meurman O, Hannonen P, Skurnik M, et al. Does parvovirus B19 have a role in rheumatoid arthritis? Ann Rheum Dis 1994;53:106-11.
11. Speyer I, Breedveld FC, Dijkmans BAC. Human parvovirus B19 infection is not followed by inflammatory joint disease during long term follow-up. A retrospective study of 54 patients. Clin Exp Rheumatol 1998;16:576-8.
12. Anderson MJ, Lewis E, Kidds IM, Hall SM, Cohen BJ. An outbreak of erythema infectiosum associated with human parvovirus infection. J Hyg (Lond) 1984;93:85-93.
13. Anderson LJ, Tsou C, Parker RA, Chorba TL, Wulff H, Tattersall P, et al. Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay. J Clin Microbiol 1986;24:522-6.
14. Cohen BJ, Buckley MM. The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Microbiol 1988;25:151-3.
15. Brown KE, Anderson SM, Young NS. Erythrocyte P. antigen: cellular receptor for B19 parvovirus. Science 1993;262:114-7.
16. Srivastava A, Lu L. Replication of B19 parvovirus in highly enriched hematopoietic progenitor cells from normal bone marrow. J Virol 1988;62:3059-63.
17. Young N. Hematologic and hematopoietic consequences of B19 parvovirus infection. Semin Hematol 1988;25:159-72.
18. Pattison JR, Jones SE, Hodgson J, Davis LR, White JM, Stroud CE, et al. Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet 1981;1:664-5.
19. Pillet S, Morinet F. Parvovirus and erythroid cells. Pathol Biol (Paris) 2002;50:349-56.
20. Tolfvenstam T, Papadogiannakis N, Norbeck O, Petersson K, Broliden K. Frequency of human parvovirus B19 infection in intrauterine fetal death. Lancet 2001;357:1494-7.
21. Miller E, Fairley CK, Cohen BJ, Seng C. Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol 1998;105:174-8.
22. Mehraein Y, Rehder H, Draeger HG, Froster-Iskenius UG, Schwinger E, Holzgreve W. Die diagnostik fetaler virusinfektionen durch in-situ-hybridisierung. Geburtshilfe Frauenheilkd 1991;51:984-9.
23. Reid DM, Reid TMS, Brown T, Rennie RAN, Eastmond CJ. Human parvovirus-associated arthritis: a clinical and laboratory description. Lancet 1985;1:422-5.
24. White DG, Woolf AD, Mortimer PP, Cohen BJ, Blake DR, Bacon PA. Human parvovirus arthropathy. Lancet 1985;1: 419-21.
25. Söderlund M, von Essen R, Haapasaari J, Kiistala U, Kiviluoto O, Hedman K. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet 1997;349:1063-5.
26. Hokynar K, Brunstein J, Söderlund-Venermo M, Kiviluoto O, Partio EK, Konttinen Y, et al. Integrity and full coding sequence of B19 virus DNA persisting in human synovial tissue. J Gen Virol 2000;81:1017-25.
27. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
28. Cotmore SF, McKie VC, Anderson LJ, Astell CR, Tattersall P. Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments. J Virol 1986;60:548-57.
29. Shade RO, Blundell MC, Cotmore SF, Tattersall P, Astell CR. Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J Virol 1986;58:921-36.
30. Cooling LLW, Koerner TAW, Naides SJ. Multiple glycosphingolipids determine the tissue tropism of parvovirus B19. J Infect Dis 1995;172:1198-205.
31. Imai Y, Sato T, Yamakawa M, Kasjima T, Suda A, Watanabe Y. A morphological and immunohistochemical study of lymphoid germ centers in synovial and lymph node tissues from rheumatoid arthritis patients with special reference to complement components and their receptors. Acta Pathol Jpn 1989;39:127-34.
32. Modrow S, Dorsch S. Antibody responses in parvovirus B19 infected patients. Pathol Biol (Paris) 2002;50:326-31.
33. Kurtzman GJ, Ozawa K, Cohen B, Hanson G, Oseas R, Young NS. Chronic bone marrow failure due to persistent B19 parvovirus infection. N Engl J Med 1987;317:287-94.
34. Lundquist A, Tolfvenstam T, Brytting M, Stolt CM, Hedman K, Broliden K. Prevalence of parvovirus B19 DNA in bone marrow of patients with haematological disorders. Scand J Infect Dis 1999;31:119-22.
35. Cassinotti P, Siegl G, Michel BA, Bruhlmann P. Presence and significance of human parvovirus B19 DNA in synovial membranes and bone marrow from patients with arthritis of unknown origin. J Med Virol 1998;56:199-204.